The FDA accepts Moderna’s mRNA flu vaccine filing, targeting adults 50 years and older, with an accelerated path for older adults and a 2026 decision deadline.
Tony Yang, ScD, LLM, MPH
Advertisement
Articles by Tony Yang, ScD, LLM, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists
2
Cyclosporiasis on the Rise in the United States, Exceeding 450 Cases
3
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
4
GLP-1 RAs Linked to Lower Mortality, Amputation Risk in Patients With PAD and Type 2 Diabetes
5